CareTrust REIT (CTRE) Stock Looks Like A Bargain On Earnings Yet Fully Priced After 134% Return
CareTrust REIT stock has delivered a strong 133.7% return over the past three years, yet its valuation checks paint a more measured picture, with signals that are positive but not uniformly compelling.
- Over the last three years, CareTrust REIT has returned 133.7%, which puts extra focus on whether the current share price already reflects much of that progress.
- For a healthcare focused REIT, the long term appeal of stable rental income can support the valuation, while any pressure on tenant quality or funding costs may weigh on how much investors are willing to pay for that cash flow.
- The stock screens as undervalued on several market multiples and is judged attractive in 4 of 6 valuation checks, a mixed profile that suggests some room for value but not a clear across the board bargain.
The issue now is whether CareTrust REIT's recent gains leave enough valuation upside to justify taking on the risks that come with the current price.
Is CareTrust REIT a Bargain on Earnings?
P/E is a useful yardstick for CareTrust REIT because earnings are a key link between its rental income and what you pay for each share. On this measure, CareTrust REIT trades at about 30.2x earnings, which sits above the Health Care REITs industry average of roughly 19.8x but below the peer group average near 60.1x. That mix indicates the stock is not the most expensive option within its peer set, even though it carries a premium to the broader industry.
The fair P/E ratio, which attempts to tailor a benchmark to CareTrust REIT based on factors such as size, sector and risk, comes out at about 40.7x. With the current multiple sitting meaningfully below that level, the stock appears undervalued on this earnings metric based on its three year share price performance. For investors focused on earnings based valuation, CareTrust REIT still appears to offer some multiple support at today’s price.
On the P/E multiple, CareTrust REIT stock appears undervalued relative to the earnings level implied by the fair ratio.
See what the numbers say about this price — find out in our valuation breakdown.
The CareTrust REIT Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for CareTrust REIT pick up where the valuation checks leave off by spelling out which paths for CareTrust REIT's future growth, margins and earnings would need to play out for the stock to be worth materially more or less than it is today, and they sit on Simply Wall St's Community page. Instead of stopping at a single ratio or model output, they lay out the future that figure relies on so you can monitor whether that story continues to fit the facts.
If you have a number driven view on where CareTrust REIT's growth, margins and execution go from here, consider adding your Narrative to the Simply Wall St community and setting out the case in one clear place.
This will allow you to track how your thesis on CareTrust REIT's valuation holds up as new information comes through and to see how it compares with what other investors are watching.
Do you think there's more to the story for CareTrust REIT? Head over to our Community to see what others are saying!
The Bottom Line
For CareTrust REIT, the current picture is that the stock screens as undervalued on market multiples, with the P/E sitting below a tailored fair ratio yet not flashing an across the board bargain. The key question is whether the income stream and tenant profile are solid enough, and funding costs contained enough, to support that premium to the broader healthcare REIT group. From here, the crux of the bull versus bear debate is whether the current valuation reflects a reasonable price for dependable cash flows or a discount that is compensating you for real risks in tenant quality and capital costs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com